Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59,794,743
-
Total 13F shares
-
38,636,557
-
Share change
-
+2,125,794
-
Total reported value
-
$171,807,935
-
Put/Call ratio
-
100%
-
Price per share
-
$4.44
-
Number of holders
-
102
-
Value change
-
+$10,287,580
-
Number of buys
-
42
-
Number of sells
-
57
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2022
As of 31 Mar 2022,
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,636,557 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, Verition Fund Management LLC, EAGLE ASSET MANAGEMENT INC, Tri Locum Partners LP, Prosight Management, LP, GOLDMAN SACHS GROUP INC, and Assenagon Asset Management S.A..
This page lists
102
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.